More articles from Volume 30, Issue 2, 2014
Uticaj kvaliteta ishrane na simptome donjih partija urotrakta
Trisomy 13 detection in the first trimester of pregnancy using a chromosome‐selective cell‐free <scp>DNA</scp> analysis method
PRIKAZI SLUČAJA CASE REPORTS
Pseudocyst of the spleen-report of two cases
Magnetic resonance imaging
Article views
KONTINUIRANA EDUKACIJA News in the diagnostics of Inflammatory Myopathies
Sanja Milenkovic
Published: 01.12.2013.
Biochemistry
Volume 30, Issue 2 (2014)
pp. 1161-1167;
Abstract
Keywords
References
1.
Goebel H, Sewry A, Weller O. 2013;
2.
Bohan A, Peter J. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;(8):403–7.
3.
Bohan A, Peter J. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;(7):344–7.
4.
Robinson A, Reed A. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol. 2011;(11):664–75.
5.
Dalakas M, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;(9388):971–82.
6.
Dimachkie M. Idiopathic inflammatory myopathies. J Neuroimmunol. 2011;(1–2):32–42.
7.
Wedderburn L, Varsani H, Li C. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum. 2007;(7):1192–201.
8.
Greenberg S, Bradshaw E, Pinkus J. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology. 2005;(11):1782–7.
9.
Greenberg S, Pinkus G, Amato A, Pinkus J. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve. 2007;(1):17–23.
10.
Chahin N, Engel A. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology. 2008;(6):418–24.
11.
Dalakas M, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;(9388):971–82.
12.
Van Der Pas J, Hengstman G, Ter Laak H, Borm G, Van Engelen B. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2004;(1):136–9.
13.
Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg I. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol. 2001;(4):1263–73.
14.
Greenberg S, Pinkus J, Pinkus G. Interferon-alpha/betamediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005;(5):664–78.
15.
Li C, Varsani H, Holton J, Gao B, Woo P, Wedderburn L. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol. 2004;(3):605–9.
16.
Visser D, M, Smith E, Engel A, A. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci. 1989;(1–3):181–92.
17.
Pestronk A, Schmidt R, Choksi R. Vascular pathology in dermatomyositis and anatomic relations to myopathology. Muscle Nerve. 2010;(1):53–61.
18.
Yunis E, Samaha F. Inclusion body myositis. Lab Invest. 1971;(3):240–8.
19.
Amato A, Barohn R. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry. 2009;(11):1186–93.
20.
Temiz P, Weihl C, Pestronk A. Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci. 2009;(1–2):25–9.
21.
Nogalska A, Terracciano C, Agostino C, Engel K, Askanas W, V. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and canhelp differentiating it from polymyositis and dermatomyositis. Acta Neuropathol. 2009;(3):407–13.
22.
Askanas V, Engel W, Nogalska A. Inclusion body myositis: a degenerative muscle disease associated with intramuscle fiber multiprotein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol. 2009;(3):493–506.
23.
Greenberg S. Theories of the pathogenesis of inclusion body myositis. Curr Rheumatol Rep. 2010;(3):221–8.
24.
Confalonieri P, Oliva L, Andreetta F. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol. 2003;(1–2):130–6.
25.
Broccolini A, Gidaro T, Morosetti R, Sancricca C, Mirabella M. Hereditary inclusion-body myopathy with sparing of the quadriceps:the many tiles of an incomplete puzzle. Acta Myol. 2011;(2):91–5.
26.
Weihl C, Pestronk A, Kimonis V. Valosin-containing protein disease: inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia. Neuromuscul Disord. 2009;(5):308–15.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
